Systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple systems and organs and has multiple autoantibodies. Tissue damage is caused by a large number of pathogenic autoantibodies and immune complexes in the body. Clinically, there may be manifestations of damage to various systems and organs, such as skin, joints, serous membranes, heart, kidneys, central nervous system, blood system, etc. The disease occurs worldwide, with a prevalence of 4/100,000 to 25/100,000. The prevalence is higher in Asia and blacks, and the prevalence in my country is 70/100,000 to 75/100,000. The incidence in women is significantly higher than that in men, about 10:1. The peak incidence is in women of childbearing age, and the elderly and children may also be ill. This disease belongs to the category of Yin-Yang poison, Yang poison spot, butterfly spot, sunburn sore, ghost face sore, and face wandering wind in traditional Chinese medicine.
Related Drugs
Danazol Capsules
Indication: It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Danazol Capsules
Indication: It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Manufacturer:
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Danazol Capsules
Indication: It is used to treat endometriosis, and can also be used to treat fibrocystic breast disease, spontaneous thrombocytopenic purpura, hereditary angioedema, systemic erythema, male gynecomastia, and precocious puberty.
Manufacturer:
Zhejiang Xianju Pharmaceutical Co., Ltd.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Manufacturer:
Chuxiong Yunzhi Phytopharmaceutical Co., Ltd.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Manufacturer:
China Resources 39 (Youyang) Pharmaceutical Co., Ltd.
Artemisinin
Indication: It is mainly used for symptom control of Plasmodium vivax malaria and Plasmodium falciparum malaria, and for the treatment of chloroquine-resistant strains. It can also be used to treat severe Plasmodium falciparum malaria, such as cerebral and icteric malaria. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
Mycophenolate mofetil
Indication: Autoimmune diseases such as pemphigus, bullous pemphigoid, systemic lupus erythematosus (SLE), psoriasis, etc.
Manufacturer:
North China Pharmaceutical Huasheng Co., Ltd.
Mycophenolate mofetil
Indication: Autoimmune diseases such as pemphigus, bullous pemphigoid, systemic lupus erythematosus (SLE), psoriasis, etc.
Manufacturer:
Chongqing Lummy LONG YU Pharmaceutical Co., Ltd.
Mycophenolate mofetil
Indication: Autoimmune diseases such as pemphigus, bullous pemphigoid, systemic lupus erythematosus (SLE), psoriasis, etc.
Manufacturer:
Jiangsu Shenlong Pharmaceutical Co., Ltd.